Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1999-11-16
pubmed:abstractText
The ABC1 transporter was identified as the defect in Tangier disease by a combined strategy of gene expression microarray analysis, genetic mapping, and biochemical studies. Patients with Tangier disease have a defect in cellular cholesterol removal, which results in near zero plasma levels of HDL and in massive tissue deposition of cholesteryl esters. Blocking the expression or activity of ABC1 reduces apolipoprotein-mediated lipid efflux from cultured cells, and increasing expression of ABC1 enhances it. ABC1 expression is induced by cholesterol loading and cAMP treatment and is reduced upon subsequent cholesterol removal by apolipoproteins. The protein is incorporated into the plasma membrane in proportion to its level of expression. Different mutations were detected in the ABC1 gene of 3 unrelated patients. Thus, ABC1 has the properties of a key protein in the cellular lipid removal pathway, as emphasized by the consequences of its defect in patients with Tangier disease.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-10092505, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-10224147, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-10407490, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-10431236, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-10431237, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-10431238, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-10525038, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-1282354, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-14162531, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-1973824, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-1998658, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-3513311, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-4868699, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-6311077, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-7503979, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-7578031, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-7615839, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-7749882, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-7945562, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-7999122, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-8088782, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-8106172, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-8473514, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-8745077, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-8894702, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-8940040, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-9006906, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-9017504, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-9300773, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-9323590, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-9327782, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-9376570, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-9731541, http://linkedlifedata.com/resource/pubmed/commentcorrection/10525055-9806540
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
R25-31
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.
pubmed:affiliation
CV Therapeutics Inc., Palo Alto, California 94304, USA. lawn@cvt.com
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't